Pinsent Masons advises Teva on £603 million sale of Actavis’ UK and Ireland generics business

09 Jan 2017 | 04:35 pm |

International law firm Pinsent Masons has advised Teva Pharmaceuticals Industries Ltd. on its agreement to sell the assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd).

Teva today announced the completion of the sale of the majority of the assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd). The sale, first announced in October last year, has completed for an agreed value of £603 million following approval from the European Commission.

Israel-headquartered Teva is a leading global pharmaceutical company and the world’s largest generic medicines producer, whose generic portfolio covers nearly every therapeutic area.

The sale includes a portfolio of generic medicines plus a manufacturing plant in Barnstaple, England. Teva retains a number of Actavis non-overlapping generic products plus certain specialty medicines and OTC (over-the-counter) products, which have been added to Teva’s existing operations.

The Pinsent Masons team was led by corporate partner Andrew Hornigold and life sciences partner, Allistair Booth, supported by a 25-strong team of lawyers.

Commenting on the deal, Andrew Hornigold said: “It’s good to see that this sizeable and very complex deal has received approval from the European Commission as expected. We’re pleased to have worked with longstanding client Teva on such an important deal for the business.”

Key Contacts

Andrew Hornigold

Andrew Hornigold

Partner, Head of Client Relationships - Advanced Manufacture & Technology

View Profile

Latest press releases

Show me all press releases

Pinsent Masons bolsters its Competition, EU & Trade Group with appointment of Hans Jürgen Meyer-Lindemann in Düsseldorf

Pinsent Masons continues to expand its Competition, EU & Trade Group, with the appointment of competition law specialist, Prof. Dr. Hans Jürgen Meyer-Lindemann, as a partner in the Düsseldorf office.

Pinsent Masons advises HZI on its first Energy from Waste Plant in Australia

International law firm Pinsent Masons has advised HZI on the development of the A$511 million East Rockingham Resource Recovery Facility in Western Australia

Pinsent Masons advises Redington on deal from Phoenix

International law firm, Pinsent Masons, has successfully advised the founders and management of Redington, the independent institutional investment consultant, on an investment deal from Phoenix Equity Partners, a leading UK mid-market private equity firm.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons bolsters its Competition, EU & Trade Group with appointment of Hans Jürgen Meyer-Lindemann in Düsseldorf

Pinsent Masons continues to expand its Competition, EU & Trade Group, with the appointment of competition law specialist, Prof. Dr. Hans Jürgen Meyer-Lindemann, as a partner in the Düsseldorf office.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts